Mounjaro for Weight Loss in Dubai: How Much Can You Lose? Results, Dosage and Side Effects

Can Mounjaro help you lose 10 or 20 kilograms? How soon does it start working, and will the weight return if you stop taking it?

Mounjaro for weight loss in Dubai has attracted increasing interest among people living with obesity or excess weight, particularly following clinical studies showing significant weight reduction with its active ingredient, tirzepatide.

The short answer: In the SURMOUNT-1 clinical trial, adults without diabetes who received tirzepatide achieved an average weight reduction of approximately 15% to 20.9% over 72 weeks, depending on the dose, alongside dietary changes and physical activity.

These findings suggest that tirzepatide can be an effective treatment option for eligible patients. However, individual results vary, and not everyone will experience the same degree of weight loss.

Mounjaro is a prescription medication, not a quick solution for weight management. Its use requires medical assessment, an appropriate dosing plan and ongoing monitoring.

In this comprehensive guide from DRFK Dubai, we explain how Mounjaro works, how much weight you may lose, when results can appear, possible side effects, recommended dosage schedules and what happens when treatment is stopped.

What Is Mounjaro for Weight Loss and How Does It Work?

Mounjaro is a prescription medication containing tirzepatide, an active ingredient administered through a once-weekly injection under the skin.

Originally developed for the treatment of type 2 diabetes, tirzepatide has also demonstrated significant weight-management benefits in clinical trials involving people with obesity or overweight.

How Does Mounjaro Help You Lose Weight?

Tirzepatide works by activating receptors for two hormones involved in appetite and blood glucose regulation:

• Glucagon-like peptide-1 (GLP-1): Helps regulate appetite, increases feelings of fullness and influences how quickly food leaves the stomach.
• Glucose-dependent insulinotropic polypeptide (GIP): Helps regulate glucose-dependent insulin secretion and contributes to metabolic processes involved in blood sugar control.

By acting on both pathways, tirzepatide may help people feel satisfied after smaller meals, reduce hunger and consume fewer calories.

It also slows gastric emptying, particularly during the early stages of treatment.

Does Mounjaro burn body fat directly?

No. Mounjaro does not directly dissolve or melt body fat. Instead, it influences appetite and food intake, potentially creating an energy deficit that leads to a gradual reduction in body weight and fat stores.

How Much Weight Can You Lose With Mounjaro?

One of the most frequently asked questions is: How much weight can you actually lose with Mounjaro?

There is no single answer for everyone.

Weight-loss outcomes depend on several factors, including starting body weight, medication dosage, treatment duration, underlying health conditions, dietary habits, physical activity and individual response.

What Did the SURMOUNT-1 Clinical Trial Show?

The SURMOUNT-1 trial, published in the New England Journal of Medicine, included 2,539 adults with obesity or overweight and at least one weight-related complication, excluding diabetes.

After 72 weeks, participants receiving tirzepatide achieved different average weight-loss outcomes depending on the weekly dose.

Those receiving 5 mg weekly lost an average of 15% of their starting body weight.

Participants receiving 10 mg weekly lost an average of 19.5%, while those receiving 15 mg weekly lost an average of 20.9%.

By comparison, participants receiving a placebo lost an average of 3.1%.

These results demonstrate the potential effectiveness of tirzepatide for weight management in the population studied.

However, the figures are clinical averages rather than guaranteed individual outcomes.

It is also important to understand that the results were measured over 72 weeks, not just a few weeks or months.

Source: SURMOUNT-1 — Tirzepatide Once Weekly for the Treatment of Obesity.

How Much Weight Could Someone Weighing 100 kg Lose?

For someone starting at 100 kilograms, losing 10% of their body weight would mean a reduction of 10 kilograms.

A 15% reduction would equal 15 kilograms, while a 20% reduction would mean losing 20 kilograms.

In this example, someone starting at 100 kg who achieves a 20% reduction would reach approximately 80 kg.

However, this is a mathematical illustration of weight-loss percentages, not a prediction for an individual patient.

Some people may experience greater reductions than the trial averages, while others may lose considerably less.

The most meaningful outcome is not simply reaching a lower number on the scale, but achieving improvements in health that can be maintained over time.

When Does Mounjaro Start Working for Weight Loss?

Some people notice reduced hunger or increased fullness during the first few weeks of treatment.

However, the timing of these effects varies, and changes in appetite do not necessarily translate into immediate weight loss.

When Does Weight Loss Start After the First Mounjaro Injection?

Weight loss may begin during the early weeks of treatment, but Mounjaro is normally introduced at a low starting dose.

This allows the body to adjust to the medication and helps reduce the likelihood of gastrointestinal side effects.

As a result, it is not appropriate to judge the effectiveness of treatment based on the first injection alone.

Some people may notice changes in their eating patterns before seeing a measurable difference in body weight.

How Long Does It Take to See Visible Mounjaro Results?

Visible changes in body shape, waist circumference or clothing size may develop gradually as weight decreases.

The timeline depends on the starting weight, individual response, dosage, nutrition and physical activity.

For some patients, changes become noticeable earlier than for others.

Progress is best evaluated over several weeks or months rather than through daily weight measurements.

How Much Weight Can You Lose With Mounjaro in a Week?

There is no fixed amount of weight that everyone should expect to lose each week while using Mounjaro.

Weight loss may be faster during some stages of treatment and slower during others.

The rate may also change as body weight decreases and the body's energy requirements become lower.

For this reason, expecting every patient to lose exactly one kilogram per week is not medically accurate.

The overall weight-loss trend is more important than achieving a particular weekly number.

A successful treatment plan should also support adequate nutrition, physical activity and the preservation of muscle mass.

How Much Weight Can You Lose With Mounjaro in a Month?

Weight loss during the first month varies according to starting weight, dosage, appetite response, dietary changes and overall health.

Some patients may notice early weight reduction, while others need more time before results become apparent.

Long-term clinical trial outcomes cannot simply be divided into equal monthly amounts because weight reduction does not occur at a constant rate.

Can Mounjaro Help You Lose 10 kg in One Month?

Losing 10 kilograms in one month is not a guaranteed or appropriate goal for everyone using Mounjaro.

Very rapid weight loss may increase the risk of dehydration, inadequate nutrition or loss of lean body mass.

Individual weight-loss goals should therefore be based on starting weight, medical history, nutritional needs and a healthcare professional's assessment.

What Are the Different Mounjaro Dosages?

Mounjaro is available in several dosage strengths, and treatment is usually introduced gradually.

The adult dose strengths include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.

The appropriate dose depends on the patient's medical condition, treatment response and ability to tolerate the medication.

What Is the Usual Starting Dose of Mounjaro?

According to the UK prescribing information, the usual adult starting dose is 2.5 mg once weekly for four weeks.

After this initial period, the dose is generally increased to 5 mg once weekly.

If additional dose increases are appropriate, they may be made in 2.5 mg increments after at least four weeks on the current dose.

For adults, 15 mg once weekly is the maximum recommended dose in the referenced prescribing information.

Important: This information is educational and should not be used as a personal dosing schedule. Patients should follow the prescribing instructions approved in the UAE and the recommendations of their treating physician.

Does Mounjaro 15 mg Produce Greater Weight Loss?

In SURMOUNT-1, participants receiving 15 mg achieved a higher average reduction in body weight than those receiving 5 mg or 10 mg.

However, a higher dose is not necessarily the best choice for every patient.

Higher doses may increase gastrointestinal side effects in some people, while others may achieve suitable results at lower doses.

The goal is to identify a medically appropriate dose that balances effectiveness, safety and tolerability.

Who Is a Suitable Candidate for Mounjaro Weight Loss Treatment?

Mounjaro may be considered for adults living with obesity or overweight accompanied by weight-related health conditions, provided they meet the relevant licensed indications and receive appropriate medical assessment.

In the UK prescribing information for adult weight management, eligibility includes people with a body mass index (BMI) of 30 or above.

Adults with a BMI of 27 to below 30 may also meet the criteria if they have at least one weight-related health condition.

Which Health Conditions May Support Eligibility for Mounjaro?

Examples of weight-related conditions considered during medical assessment include:

• High blood pressure (hypertension): Particularly when elevated blood pressure occurs alongside excess body weight.
• High cholesterol or dyslipidaemia: Including abnormal cholesterol or triglyceride levels.
• Obstructive sleep apnoea: A condition involving repeated interruptions or reductions in breathing during sleep.
• Cardiovascular disease: Including certain conditions affecting the heart and blood vessels.
• Prediabetes: When blood glucose levels are elevated but remain below the diagnostic threshold for type 2 diabetes.
• Type 2 diabetes: Particularly when excess weight is also an important part of the patient's overall health condition.

Having one of these conditions does not automatically mean that Mounjaro is suitable.

A prescribing decision should consider the person's medical history, current medications, possible contraindications and overall treatment goals.

How Do You Know if Mounjaro Is Right for You?

Eligibility cannot be determined by body weight or BMI alone.

A medical assessment should also examine existing health conditions, medication interactions, previous weight-management attempts and individual risk factors.

At DRFK Dubai, patients can request a medical assessment to discuss weight-related health concerns and appropriate management options.

Book a Medical Consultation at DRFK Dubai

Can You Use Mounjaro for Weight Loss Without Diabetes?

Yes. Tirzepatide may be used for weight management in eligible adults without diabetes where the product is licensed for that indication.

SURMOUNT-1 specifically studied adults who did not have diabetes and demonstrated significant average reductions in body weight.

However, eligibility depends on the complete medical picture rather than diabetes status alone.

Can You Use Mounjaro to Lose Just 5 kg?

Not necessarily.

Wanting to lose a small amount of weight for cosmetic reasons does not automatically justify treatment with a prescription obesity medication.

For some individuals, dietary changes, physical activity or evaluation of underlying causes of weight gain may be more appropriate.

Who Should Avoid Mounjaro or Use It With Special Caution?

Mounjaro is not suitable for everyone, and certain medical conditions require particular attention before treatment is prescribed.

Patients should inform their healthcare professional about a history of pancreatitis, gallbladder disease, severe gastrointestinal problems or conditions involving delayed stomach emptying.

Kidney problems, dehydration risk and concurrent diabetes medications are also important considerations.

Individuals should disclose any previous serious allergic reaction to tirzepatide or another ingredient in the formulation.

Pregnancy and plans to become pregnant must also be discussed before treatment.

The US prescribing information includes contraindications relating to a personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2 (MEN2).

Regulatory warnings and contraindications can differ between countries, so the prescribing information applicable to the product supplied in the UAE must be consulted.

What Are the Side Effects of Mounjaro for Weight Loss?

Although Mounjaro can support weight management, it may cause side effects that vary in frequency and severity.

What Are the Most Common Mounjaro Side Effects?

Commonly reported side effects include nausea, vomiting, diarrhoea, constipation, indigestion, abdominal discomfort and reduced appetite.

Gastrointestinal symptoms are often more noticeable when treatment begins or after the dose is increased.

Some symptoms may improve as the body adjusts, but persistent or severe symptoms require medical assessment.

Can Mounjaro Cause Pancreatitis?

Acute pancreatitis is an important potential complication associated with tirzepatide.

Symptoms may include severe, persistent abdominal pain that sometimes spreads to the back, with or without vomiting.

If pancreatitis is suspected, urgent medical assessment is necessary. Another dose should not be taken until appropriate medical advice has been obtained.

Can Mounjaro Affect Kidney Function?

Severe vomiting or diarrhoea may cause dehydration, potentially leading to deterioration in kidney function.

This is particularly important for people with pre-existing kidney disease or other factors that increase dehydration risk.

Patients who cannot keep fluids down or develop signs of significant dehydration should seek medical advice promptly.

Can Mounjaro Cause Low Blood Sugar?

Low blood sugar, also called hypoglycaemia, can occur, particularly when tirzepatide is used with insulin or certain other diabetes medications, including sulfonylureas.

Patients taking these medicines may require closer blood glucose monitoring and adjustments directed by their treating clinician.

When Should You Seek Urgent Medical Attention?

Medical evaluation should not be delayed if any of the following occurs:

• Severe, persistent abdominal pain, especially if it spreads to the back.
• Repeated vomiting with signs of dehydration.
• Severe upper abdominal pain accompanied by fever or yellowing of the skin.
• Swelling of the face or tongue, or difficulty breathing.
• Symptoms of severe hypoglycaemia, including confusion or loss of consciousness.

Patients should also inform their medical and anaesthesia teams if they use Mounjaro before surgery or procedures requiring general anaesthesia or deep sedation.

Because tirzepatide delays gastric emptying, additional precautions may be needed to manage aspiration risk.

Can Mounjaro Cause Hair Loss?

Some people experience hair shedding during significant weight loss, particularly when weight decreases rapidly or nutritional intake becomes inadequate.

However, hair loss during treatment does not necessarily mean tirzepatide is the direct cause.

Other factors, such as iron deficiency, thyroid disorders or insufficient protein intake, may contribute.

Persistent or noticeable hair loss should be evaluated rather than automatically attributed to the medication.

Does Mounjaro Cause Muscle Loss?

Weight reduction can involve a decrease in lean body mass as well as fat mass.

This is why an appropriate weight-management programme should consider nutritional quality, adequate protein intake and physical activity.

Resistance exercises, when medically suitable, can help preserve strength and support muscle health.

The aim should be more than achieving a lower weight. Maintaining physical function and long-term health is equally important.

Is Mounjaro Safe During Pregnancy?

Tirzepatide should not be used during pregnancy.

According to the UK product information, it should be discontinued at least one month before a planned pregnancy.

Patients should discuss pregnancy plans with their healthcare professional before starting treatment.

Does Mounjaro Affect Birth Control?

Tirzepatide may reduce the effectiveness of oral contraceptives in some users.

Guidance therefore recommends considering a non-oral contraceptive method or using additional barrier contraception for four weeks after starting treatment and for four weeks following each dose increase.

The most appropriate contraceptive approach should be discussed with a healthcare professional.

Can Mounjaro Be Used While Breastfeeding?

Breastfeeding advice requires an individual medical assessment.

Regulatory information has evolved as additional data have become available, and recommendations may differ between product labels and authorities.

Patients should consult their clinician and the currently applicable UAE prescribing information before considering tirzepatide while breastfeeding.

How Long Does Mounjaro Stay in Your System?

Mounjaro is administered once weekly, but this does not mean the medication completely disappears from the body after seven days.

Tirzepatide has an elimination half-life of approximately five days.

This means the amount of medicine remaining in the body decreases gradually after the last dose.

The medication may therefore remain in the body for a period after treatment has stopped.

What Happens if You Miss a Mounjaro Dose?

According to the UK prescribing information, a missed dose may be taken within four days of the scheduled injection.

If more than four days have passed, the missed dose should generally be skipped and the next dose taken on the regular scheduled day.

Patients should not take extra doses to compensate.

Always follow the instructions provided with the locally approved product and consult the prescribing clinician when uncertain.

Will You Regain Weight After Stopping Mounjaro?

Yes, some weight regain may occur after stopping Mounjaro, even in people who achieved substantial weight loss during treatment.

This is one of the most important considerations for anyone planning to use tirzepatide.

The SURMOUNT-4 trial evaluated what happened when participants continued tirzepatide compared with switching to a placebo.

During the initial 36-week treatment period, participants lost an average of approximately 20.9% of their body weight.

Participants were then assigned either to continue treatment or to receive a placebo.

Over the following 52 weeks, the group that discontinued tirzepatide regained an average of 14% of their weight measured at the start of that comparison period.

Meanwhile, participants continuing tirzepatide lost an additional 5.5% on average.

These findings indicate that stopping treatment can be followed by substantial weight regain and highlight the importance of long-term weight-management planning.

Source: SURMOUNT-4 — Continued Treatment With Tirzepatide for Maintenance of Weight Reduction.

How Can You Reduce the Risk of Weight Regain?

Long-term weight management requires more than medication alone.

A suitable plan may include balanced nutrition, regular physical activity, resistance exercise, adequate sleep and continued monitoring of weight-related health conditions.

Patients should discuss any decision to continue, modify or stop treatment with their healthcare professional.

Obesity is a chronic, multifactorial condition, and some individuals may need longer-term medical support.

Is Mounjaro Better Than Ozempic for Weight Loss?

Mounjaro contains tirzepatide, while Ozempic contains semaglutide.

Although both medications influence pathways involved in appetite and blood glucose regulation, their mechanisms differ.

Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide acts on GLP-1 receptors.

What Do Comparative Clinical Trials Show?

In the SURMOUNT-5 trial, researchers compared tirzepatide with semaglutide using doses studied for obesity management in adults without diabetes.

After 72 weeks, participants receiving tirzepatide achieved an average weight reduction of 20.2%, compared with 13.7% among those receiving semaglutide.

However, this study used weight-management doses of semaglutide and should not be interpreted as a direct comparison with every Ozempic dosage or every product containing semaglutide.

Importantly, a medication that produces greater average weight loss in a study is not necessarily the best option for every patient.

Treatment selection depends on approved indications, medical history, other medications, side effects and individual health goals.

Source: SURMOUNT-5 — Tirzepatide Compared With Semaglutide for Obesity.

Why Does Weight Loss Sometimes Stop While Taking Mounjaro?

Some patients experience a weight-loss plateau despite continuing treatment.

This can occur for several reasons.

As body weight decreases, the body's energy requirements may also decline.

Changes in dietary habits, reduced physical activity, individual metabolic responses and certain medications or health conditions can also affect progress.

A brief period of stable weight does not necessarily mean Mounjaro has stopped working.

However, a prolonged plateau may warrant a review of the treatment plan, nutritional intake, physical activity and other factors influencing body weight.

Patients should not increase their dose without medical supervision.

What Medical Tests Are Needed Before Starting Mounjaro?

There is no single set of laboratory tests required for every patient considering tirzepatide.

The assessment should be adapted to the individual's health status and risk factors.

A healthcare professional may evaluate body weight, height, BMI, waist circumference and blood pressure.

The consultation should also review medical history, current medications, previous weight-management efforts and possible contraindications.

Depending on the patient's circumstances, blood tests may be considered to assess glucose regulation, kidney function, lipid levels or other relevant health concerns.

The purpose of this assessment is to identify associated health conditions and establish whether medication is an appropriate part of the weight-management plan.

Patients in Dubai can learn more about Family Medicine services at DRFK, which include preventive healthcare and chronic disease assessment.

DRFK also provides Executive Health Checkup services for patients requiring a broader preventive health evaluation when clinically appropriate.

Why Is Medical Monitoring Important During Mounjaro Treatment?

Successful weight management involves more than receiving a weekly injection.

Regular medical follow-up helps evaluate treatment response, medication tolerability and any emerging side effects.

It also provides an opportunity to review other medications, monitor relevant health indicators and address nutritional or physical activity needs.

Some patients may require further assessment if their weight loss is unexpectedly rapid, side effects persist or progress remains limited.

Long-term monitoring can also support planning for weight maintenance.

The overall aim is to improve health in a sustainable way, rather than focusing exclusively on rapid weight reduction.

Considering Mounjaro for Weight Loss in Dubai? Start With a Medical Assessment

If you are living with obesity or overweight, an individual medical assessment is an important first step before considering prescription weight-management medication.

At DRFK Turkish Medical Centre in Jumeirah 3, Dubai, patients can access family medicine, preventive healthcare and general medical assessment services.

A consultation can help identify weight-related health concerns, review medical history and determine whether additional investigations or specialist input may be appropriate.

Patients should confirm the availability of a specific tirzepatide prescribing service or specialised weight-management consultation directly with the centre before booking.

Is Mounjaro Right for You? Book a Medical Consultation at DRFK Dubai

If previous efforts to manage your weight have not produced the results you hoped for, it may be helpful to discuss your health and available treatment options with a qualified healthcare professional.

Book a medical assessment at DRFK Dubai to review your health, identify relevant risk factors and discuss the weight-management options that may be appropriate for your individual needs.

Book a Medical Appointment at DRFK Dubai

Location: Villa 2, Al Athar Street, Jumeirah 3, Dubai, United Arab Emirates.

Frequently Asked Questions About Mounjaro for Weight Loss

Does Mounjaro Help Reduce Belly Fat?

Mounjaro may help reduce overall body fat as weight decreases, including some fat stored around the abdomen. However, it does not specifically target belly fat, and the pattern of fat loss differs between individuals.

How Much Weight Can You Lose on Mounjaro 2.5 mg?

There is no guaranteed amount of weight loss associated with the 2.5 mg starting dose. This dose is generally used to help the body adjust to treatment before increasing to an appropriate maintenance dose.

Can You Lose Weight With Mounjaro Without Dieting?

Mounjaro may reduce appetite and food intake, but the major clinical trials combined medication with dietary changes and increased physical activity. A balanced, sustainable eating plan remains an important part of treatment.

Does Mounjaro Cause Nausea?

Yes. Nausea is one of the commonly reported side effects, particularly when beginning treatment or increasing the dose. Persistent or severe nausea requires medical assessment.

Can Mounjaro Cause Constipation?

Yes. Constipation may occur in some patients. Severe constipation, especially when accompanied by persistent pain or vomiting, should be evaluated by a healthcare professional.

Is Mounjaro Safe for People With Thyroid Problems?

It depends on the type of thyroid condition and the patient's medical history. Certain thyroid cancer histories require particular attention. Patients should discuss thyroid disorders and relevant family history with their clinician before treatment.

Can You Take Mounjaro During Pregnancy?

No. Tirzepatide should not be used during pregnancy. Patients planning pregnancy should discuss when to stop treatment with their doctor.

Can You Take Mounjaro Every Five Days?

Mounjaro is normally administered once weekly. Patients should not shorten their regular dosing interval or change the schedule without appropriate medical guidance.

Does Appetite Return After Stopping Mounjaro?

Appetite may increase after treatment is stopped, and some people experience weight regain. A long-term weight-management plan can help support maintenance.

Is Mounjaro Safe for Long-Term Use?

Clinical studies have followed patients over extended periods, but ongoing treatment still requires individual assessment of benefits, risks, side effects and tolerability.

Can You Take Mounjaro if You Do Not Have Diabetes?

Yes, tirzepatide may be appropriate for weight management in eligible adults without diabetes where the medicine is approved for that use. A medical assessment is still required.

How Long Should You Stay on Mounjaro for Weight Loss?

Treatment duration varies according to health status, response, tolerability and long-term goals. Some patients may require extended medical management, while others need their treatment plan reassessed.

Can Mounjaro Cause Fatigue or Dizziness?

Some people experience fatigue or dizziness, particularly when food intake is substantially reduced, dehydration occurs or blood glucose levels fall. Persistent or severe symptoms should be assessed.

Can Mounjaro Be Used at Any Age?

No. Age-related indications depend on the condition being treated and the regulatory approval of the specific product. Approval for type 2 diabetes in a particular age group does not automatically mean approval for weight management in the same group.

Can Mounjaro Be Used Without a Prescription in Dubai?

Mounjaro is a prescription medication. It should be obtained through appropriately licensed healthcare and pharmacy channels in accordance with UAE requirements.

Conclusion: Is Mounjaro for Weight Loss the Right Choice for You?

Clinical research has shown that tirzepatide can support meaningful weight reduction in eligible people living with obesity or overweight accompanied by related health conditions.

However, individual results vary, treatment may cause side effects, and weight regain can occur after stopping the medication.

Decisions about Mounjaro should not be based solely on dramatic weight-loss stories or expectations of rapid results.

The real goal is not to lose the greatest amount of weight in the shortest time, but to improve health and achieve results that can be managed safely over the long term.

If you are considering medical options for weight management, you can book a health assessment at DRFK Dubai to discuss your condition and available healthcare options.

Medical References and Scientific Sources

1. •Tirzepatide Once Weekly for the Treatment of Obesity — New England Journal of Medicine, 2022. The SURMOUNT-1 clinical trial evaluating weight-loss outcomes with tirzepatide over 72 weeks.
2. •Continued Treatment With Tirzepatide for Maintenance of Weight Reduction — JAMA, 2024. The SURMOUNT-4 trial investigating continued treatment and weight regain following withdrawal.
3. •Tirzepatide as Compared With Semaglutide for the Treatment of Obesity — New England Journal of Medicine, 2025. The SURMOUNT-5 trial comparing tirzepatide and semaglutide for weight management.
4. •Mounjaro — Summary of Product Characteristics. UK prescribing information covering indications, dosing, contraindications, warnings and potential adverse effects.
5. •GLP-1 Medicines for Weight Loss and Diabetes: What You Need to Know — MHRA. UK medicines regulator guidance on treatment safety, pregnancy, contraception and important precautions.

Content Review by the DRFK Team

This article has been reviewed in collaboration with the DRFK team, using published clinical studies and established medical references to support accurate, clear and reliable information about Mounjaro, tirzepatide, weight-management outcomes, dosage and potential side effects.

Medical disclaimer: This article is provided for educational purposes and does not replace professional medical advice, diagnosis or treatment. Medication suitability, dosage and contraindications must be determined by an appropriately qualified healthcare professional using the relevant prescribing information approved in the UAE.